Table 1.
Pre-HAART characteristics of the study population.
| Variables | NNRTI | PI | p value | |
|---|---|---|---|---|
| n = 43 | N = 44 | |||
| 25-(OH)D (ng/ml) | mean ± SD | 26.6 ± 13.5 | 22.6 ± 8.9 | 0.101 |
| Sex Male | n (%) | 38 (88.4) | 34 (77.3) | 0.256 |
| Dark skin color | n (%) | 7 (16.3) | 10 (22.7) | 0.590 |
| Pre-HAART sampling | ||||
| Winter | n (%) | 15 (34.9) | 17 (38.6) | 0.657 |
| Spring | n (%) | 5 (11.6) | 8 (18.2) | |
| Summer | n (%) | 11 (25.6) | 11 (25.0) | |
| Fall | n (%) | 12 (27.9) | 8 (18.2) | |
| Age (years) | median (IQR) | 38.6 (30.8;44.8) | 37 (31.8;44.6) | 0.929 |
| Weight (Kg)α | median (IQR) | 73 (68;85) | 70.5 (65.3;83.5) | 0.675 |
| CD4 (cells/mm3) | ||||
| Nadir | median (IQR) | 224 (181;292) | 247.5 (182;314.5) | 0.61 |
| pre-HAART | median (IQR) | 254 (183;338) | 299 (241;390.5) | 0.052 |
| Viral Load (log10) | median (IQR) | 5.24 (4.95;5.53) | 5.5 (4.97;5.86) | 0.168 |
| HIV stage (CDC) | ||||
| A | n (%) | 31 (72.1) | 32 (72.7) | 0.640 |
| B | n (%) | 8 (18.6) | 6 (13.6) | |
| C | n (%) | 4 (9.3) | 6 (13.6) |
PI: Protease inhibitors; NNRTI: non-nucleoside reverse transcriptase inhibitors; SD: Standard deviation; IQR: Interquartile range; α n = 85